This study revealed the cross downregulation between CDK6 and PI3K in cdk6 deficient cancer cell populations, demonstrated that CDK6-PI3K axis could be new target for inhibiting ABCB1-mediated MDR. This evidence concerns the gene PIK3CA and cancer.